Interaction between clopidogrel and proton pump inhibitors.
Allen
Michael J
MJ
McLean-Veysey
Pamela
P
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000494:pharmacology; D016022:Case-Control Studies; D000077144:Clopidogrel; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D016017:Odds Ratio; D000077402:Pantoprazole; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors / Q000494:pharmacology*; D018570:Risk Assessment; D055502:Secondary Prevention; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D000077402:Pantoprazole; D013988:Ticlopidine